UFP Technologies/$UFPT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About UFP Technologies

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Ticker

$UFPT
Sector
Primary listing

Employees

4,146

UFP Technologies Metrics

BasicAdvanced
$1.6B
24.06
$8.62
1.14
-

What the Analysts think about UFP Technologies

Analyst ratings (Buy, Hold, Sell) for UFP Technologies stock.

Bulls say / Bears say

UFP posted record Q1 2025 results with revenue up 41%, operating income rising 45%, net income up 35%, and its MedTech business surging 50%, mainly due to robust demand in Safe Patient Handling (Reuters)
In Q2 2025, UFP reported 37% year-over-year sales growth to $151.2 million, a 27% increase in adjusted EPS to $2.50, and 46% MedTech sales growth, driven by 5% organic growth and strategic acquisitions (Reuters)
UFP’s Q4 2024 performance demonstrated continued momentum, with sales up 41.9% to $144.1 million, adjusted EPS of $2.46, and MedTech unit sales increasing 48.6%, providing a solid base entering FY2025 (Reuters)
Customer concentration remains high, with Intuitive Surgical and Stryker representing about 28.8% and 15.4% of UFP’s net sales in 2024, respectively, exposing the company to potential revenue swings if either account declines (SEC.gov)
Shares declined 2% after Wolfpack Research reported a 38% year-over-year drop in shipments to UFP's largest customer, Intuitive Surgical, suggesting possible insourcing and supplier competition risk for 29% of revenue (Reuters)
The Advanced Components segment shrank 15% in Q1 2025, highlighting the weakness of UFP’s non-medical operations and its narrow business focus outside MedTech (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.

UFP Technologies Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

UFP Technologies Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $UFPT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs